No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
THC240621P125000
- 1.03
- -0.16-13.45%
15min DelayClose May 31 16:00 ET
1.92High1.03Low
1.92Open1.19Pre Close4 Volume782 Open Interest125.00Strike Price546.00Turnover35.25%IV-8.21%PremiumJun 21, 2024Expiry Date0.00Intrinsic Value100Multiplier19DDays to Expiry1.03Time Value100Contract SizeAmericanOptions Type-0.1488Delta0.0212Gamma154.54Leverage Ratio-0.0631Theta-0.0100Rho-22.99Eff Leverage0.0721Vega
Intraday
- 5D
- 1D
News
Form 144 | Tenet Healthcare(THC.US) Director Proposes to Sell 1.27 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 31, $Tenet Healthcare(THC.US)$ Director KERREY J ROBERT intends to sell 9,500 shares of its common stock on May 31, with a total market value of approximately $1.27 million
Form 144 | Tenet Healthcare(THC.US) Director Proposes to Sell 1.92 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 30, $Tenet Healthcare(THC.US)$ Director KERREY J ROBERT intends to sell 14,322 shares of its common stock on May 30, with a total market value of approximately $1.92 millio
Tenet Healthcare Price Target Raised to $140.00/Share From $107.00 by JP Morgan
Tenet Healthcare Price Target Raised to $140.00/Share From $107.00 by JP Morgan
Tenet Healthcare Is Maintained at Buy by Deutsche Bank
Tenet Healthcare Is Maintained at Buy by Deutsche Bank
Express News | Deutsche Bank Maintains Buy on Tenet Healthcare, Raises Price Target to $150
Tenet Healthcare (THC) Gains 89% in a Year: More Room to Run?
Comments
$Scynexis(SCYX.US$
$Nanoviricides(NNVC.US$
$Tenet Healthcare(THC.US$
I want to watch these the most, I think, and now to find stuff in a different sector..
$Nanoviricides(NNVC.US$
$Tenet Healthcare(THC.US$
I want to watch these the most, I think, and now to find stuff in a different sector..
1
The landscape of U.S. equities is abuzz with anticipation as artificial intelligence (AI) cements its place as a transformative force in the technology sector. In a recent analysis by $Goldman Sachs(GS.US$, optimism for AI integration remains robust, yet valuations steer clear of the vertiginous heights of previous market bubbles.
Goldman Sachs' insights reveal that market-implied long-term growth expectations hav...
Goldman Sachs' insights reveal that market-implied long-term growth expectations hav...
75
1
The significant stock sale by an insider at a lower price is seen as a negative signal. However, high insider ownership in Tenet Healthcare may indicate the company's interest in all shareholders. The absence of insider buying over the past year, despite profitability and growth, could be worrying.
Insider selling of Tenet Healthcare's stock below current price is discouraging, suggesting satisfaction with lower valuation. High insider ownership is positive, indicating alignment with shareholders. Yet, lack of recent insider buying and selling activity prompts caution.
Tenet Healthcare's respectable ROE is overshadowed by its high debt level, increasing risk and limiting future options. A high ROE without debt signifies a high-quality business. Between two companies with equal ROE, the less indebted one is preferred.
Read more